Skip to main content
INVION LIMITED logo

INVION LIMITED — Investor Relations & Filings

Ticker · IVX ISIN · AU000000IVX4 LEI · 529900JY0HVEQEMSSJ32 ASX Professional, scientific and technical activities
Open in API
Filings indexed 1,119 across all filing types
Latest filing 2019-11-03 Director's Dealing
Country AU Australia
Listing ASX IVX

About INVION LIMITED

https://inviongroup.com

Invion Limited is a life sciences company dedicated to the development and commercialization of Photosoft technology, a next-generation Photodynamic Therapy (PDT). The company focuses on utilizing this light-activated treatment platform to target various forms of cancer and infectious diseases. Photosoft technology is derived from natural chlorophyll and is designed to selectively destroy malignant cells while minimizing damage to healthy tissue. Invion's research and development efforts are primarily directed toward oncology applications, including the treatment of skin, lung, and ovarian cancers, as well as addressing global health challenges through the treatment of viral and bacterial infections. The company aims to provide non-invasive or minimally invasive therapeutic alternatives that offer improved patient outcomes and reduced side effects compared to conventional treatment modalities.

Recent filings

Filing Released Lang Actions
App 3Z - Director's Final Interests Notice - G Collier 2 pages 188.7KB
Director's Dealing Classification · 100% confidence The document is titled 'Appendix 3Z Final Director’s Interest Notice' and references ASX listing rule 3.19A.3 and section 205G of the Corporations Act. It details the cessation of a director and the director's relevant interests in securities, including indirect holdings and interests in contracts. The content focuses on reporting personal share transactions and interests of a company director. The document length is 2582 characters, which is relatively short and specific to director dealings. This matches the definition of 'Director's Dealing' filings, which report personal share transactions by company directors and executives (insider trades). Therefore, the correct classification is DIRS.
2019-11-03 English
App 3X - Initial Directors Interest Notice - C Newton 2 pages 364.0KB
Director's Dealing Classification · 100% confidence The document is titled 'Appendix 3X Initial Director’s Interest Notice' and references ASX listing rule 3.19A.1 and section 205G of the Corporations Act. It details the director's relevant interests in securities, including share options and other holdings. The document is a formal notification of a director's personal share transactions or holdings, which aligns with the definition of Director's Dealing filings. The document length is short and focused solely on director interests, with no financial statements or broader company information. Therefore, it fits the category of Director's Dealing (DIRS).
2019-11-03 English
Pre-clinical research agreement with Peter MacCallum CC 3 pages 255.8KB
Regulatory Filings Classification · 95% confidence The document is an ASX announcement detailing a new research collaboration between Invion Limited and the Peter MacCallum Cancer Centre for pre-clinical development of photodynamic therapy. It focuses on the scope and objectives of the research partnership, background on the companies, and contact information. There are no financial statements, earnings data, regulatory certifications, or voting results. The content is a corporate announcement about a research collaboration rather than a financial report, management change, or regulatory filing. Therefore, it fits best under the category of a general regulatory announcement or compliance document that does not fit other specific categories, which corresponds to Regulatory Filings (RNS).
2019-10-30 English
Appendix 3B - issue of options to incoming CEO 12 pages 528.7KB
Capital/Financing Update Classification · 100% confidence The document is titled 'Appendix 3B New issue announcement' and contains detailed information about the issuance of new securities, including the number and class of securities issued, terms of the securities, issue price, purpose of the issue, and compliance with ASX listing rules. It includes sections on placement capacity calculations under ASX rules 7.1 and 7.1A, and a quotation agreement for the new securities. The document is a formal announcement related to the issuance and quotation of additional securities by Invion Limited. This type of document is a regulatory filing specific to capital raising and share issuance activities, commonly known as an 'Appendix 3B' in the Australian Securities Exchange (ASX) context. It is not a financial report, earnings release, or management discussion, but rather a formal announcement of a capital/financing update. Therefore, the appropriate classification is 'Capital/Financing Update' (CAP). The document length (15,000 characters) and content confirm it is a full announcement, not just a brief notice or report publication announcement.
2019-10-30 English
Appendix 4C - September 2019 quarter 5 pages 22.4KB
Interim / Quarterly Report Classification · 100% confidence The document is titled 'Appendix 4C Quarterly report for entities subject to Listing Rule 4.7B' and contains detailed financial data including consolidated statements of cash flows, payments to directors, financing facilities, and estimated cash outflows for the next quarter. It covers a specific quarter ended 30-September-2019 and includes substantive financial data and analysis. The document is 8733 characters long, which is sufficient to be a full report rather than a brief announcement. The content aligns with a quarterly financial report rather than an annual report or earnings release. Therefore, the document fits the definition of an Interim / Quarterly Report (IR). Q1 2019
2019-10-28 English
C Newton to commence as CEO - Material terms of appointment 1
Board/Management Information Classification · 95% confidence The document is an announcement regarding the appointment of a new CEO, including material terms of the appointment such as salary, bonuses, and stock options. It also mentions the retirement of the previous CEO and his new role on the board. There is no financial report, earnings data, or regulatory filing related to financial performance. The content fits the category of management changes rather than financial results or other report types. Therefore, the document is best classified as Board/Management Information (MANG). The document length is short and focused solely on management changes, supporting this classification with high confidence.
2019-10-23 English

Browse filings by year

18 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.